Gateway 2012: Sartorius Stedim Biotech - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: Sartorius Stedim Biotech


Sartorius Stedim Biotech
5 Orville Drive, Bohemia, NY 11716
Contact:
PH: (800) 368-7178
FX: (631) 254-4253
www.sartorius-stedim.com

Company Description:

Sartorius Stedim Biotech is a leading provider of cutting edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management, and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely, and economically. For the next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific research community, and closely allied with customers and technology partners, the company is dedicated to its philosophy of “turning science into solutions” on a daily basis.

Sartoguard® 0.1 and 0.2µm nominal Prefilters

Sartorius Stedim Biotech is the first major filter supplier to launch two new unique Integrity Testable, bacterially retentive to LRV=6/cm2 Prefilters: Sartoguard® PES/GF 0.1 and 0.2 µm nominal. They combine excellent clarification capabilities of GF layers with exceptional throughput performance of PES membranes. Sartoguard® offers significant performance benefits in many Biopharmaceutical applications including Media Prefiltration, turbidity/aggregates removal in DSP; and Bioburden reduction in Cell Harvest/Downstream Intermediates. Please visit us at INTERPHEX at Booth #2805 or at www.sartorius.com/sartoguard to learn more.

Application Notes:
Rapid and scalable buffer preparation with SAFC powdered buffers and Sartorius Stedim Biotech single-use magnetic mixer
Rapid and scalable media preparation with SAFC powdered media and Sartorius Stedim Biotech single-use magnetic mixing systems
1,500 L and 2,500 L buffer and media preparations with SAFC ready to use powder and Sartorius Stedim Biotech Flexel for Magnetic Mixer
Rapid and scalable feed preparation with SAFC powdered soy hydrolysates or yeastolates and Sartorius Stedim Biotech single-use magnetic mixing systems

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
25%
To select processes for both new and legacy products
20%
Do not use QbD
23%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search

Click here